Biotech Values

[DewDiligence]

Wall Street is acting as though all HCV cases in the “developed” world were genotype-1.

If genoptype-1 did not exist, the other HCV genotypes would still be a major, major unmet medical need. VX-950 is not even being tested in the non-1 genotypes.